Skip to main content
OpenTrials

Clinical trial condition

Histiocytosis, Non-Langerhans-Cell

Explore clinical trials studying Histiocytosis, Non-Langerhans-Cell. Study availability and eligibility vary by location and protocol.

130 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Histiocytosis, Non-Langerhans-Cell trial results

Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details
Recruiting

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

NCT04079179

Conditions
Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
View Trial Details
Recruiting

CytOSorb TreatMent Of Critically Ill PatientS Registry

NCT05146336

Conditions
Acute Liver Failure, Acute Respiratory Distress Syndrome, Acute on Chronic Liver Failure, +60 more
Locations
  • Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Universitätsklinikum Aachen Aachen, Germany
  • Herz- und Diabeteszentrum Nordrhein-Westfalen Bad Oeynhausen, Germany
View all 28 locations
View Trial Details
Recruiting

International Rare Histiocytic Disorders Registry (IRHDR)

NCT02285582

Conditions
ALK-positive Histiocytosis, Collagen Diseases, Connective Tissue Diseases, +27 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 15 locations
View Trial Details

Related conditions